Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

The woman was misdiagnosed with Graves Disease, leading to incorrect treatment, while she actually had Pituitary Resistance to Thyroid Hormone.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Hair loss in older men is linked to higher rates of diabetes and high blood pressure.

Fibroblasts help understand androgen resistance at the cellular level.

Activated protein C helps protect mice from long-term radiation damage.

PCOS-related acne can be managed by targeting hormones and insulin resistance.

CRISPR/Cas9 gene-editing shows promise for improving sheep and goat breeding but faces challenges with efficiency and accuracy.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Insulin resistance and hyperinsulinism are linked to fertility issues and can worsen symptoms of PCOS.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

A new gene mutation causes vitamin D resistance and hair loss in two unrelated girls.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Certain genetic markers may increase or decrease prostate cancer risk.

The plant pathogen in Australia evolves through existing genetic variation, not new genotypes.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Consider Werner syndrome in young patients with early aging signs and metabolic issues.